Literature DB >> 8465432

OKT3 antibody response study: comparative testing of human antimouse antibody.

J A Kimball1, D J Norman, C F Shield, T J Schroeder, P Lisi, M Garovoy, J B O'Connell, F Stuart, S V McDiarmid, W Wall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8465432

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

Authors:  M I Wilde; K L Goa
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

2.  OKT3 monitoring in the treatment of steroid-resistant acute rejection of hepatotransplant recipients.

Authors:  P Brusa; R Casullo; F Dosio; L Cattel; S Beltramini; R Chiappetta; L Tosetti; E Andorno; M Salizzoni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

Review 3.  Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

Authors:  K Kuus-Reichel; L S Grauer; L M Karavodin; C Knott; M Krusemeier; N E Kay
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

4.  Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation.

Authors:  W J Wall; C N Ghent; A Roy; V C McAlister; D R Grant; P C Adams
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.